← back to search

Keqin Hua

Fudan University · CN
Area of research
Obstetrics and Gynecology · Rheumatology
Research interest
Research interests include Endometrial and Cervical Cancer Treatments, Gynecological conditions and treatments, Pelvic floor disorders treatments, and Endometriosis Research and Treatment.
h-index
43
citations
8,471
works
383
NIH funding
primary concept
email

Recent publications

Therapeutic strategy for cervical gastric-type adenocarcinoma by targeting CLU to relieve CLU-associated stress and sensitize chemotherapy.
2026cited by 0position: contributordoi
Update of incidence and survival in patients with cervical cancer in the United States from 2000 to 2021.
2026cited by 0position: contributordoi
The Role of Bacterial Outer Membrane Vesicles in Tumor Development: Facts, Potential Applications and Future Perspectives.
2026cited by 0position: contributordoi
Single-cell RNA sequencing reveals tumor heterogeneity in small cell neuroendocrine cervical carcinoma.
2025cited by 8position: contributordoi
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
Journal of Clinical Oncology 2025cited by 6position: middledoi
Genetically platform presenting CD24 ScFv enhance antitumor immunity by restoring macrophage phagocytosis and modulating the immune environment
Cell Communication and Signaling 2025cited by 5position: middledoi
Targeting Glutamine Metabolism Transporter SLC25A22 Enhances CD8+ T-Cell Function and Anti-PD-1 Therapy Efficacy in Cervical Squamous Cell Carcinoma: Integrated Metabolomics, Transcriptomics and T-Cell-Incorporated Tumor Organoid Studies.
2025cited by 2position: contributordoi
Dual‐Crosslinked Bioactive Hydrogel Scaffold for Accelerated Repair of Genital Tract Defect
Advanced Functional Materials 2024cited by 14position: contributordoi
Dissecting the Distinct Tumor Microenvironments of HRD and HRP Ovarian Cancer: Implications for Targeted Therapies to Overcome PARPi Resistance in HRD Tumors and Refractoriness in HRP Tumors.
2024cited by 13position: contributordoi
A long-term retrospective analysis of management of cervical cancer during pregnancy.
2024cited by 6position: contributordoi
Impact of peritoneal vaginoplasty combined with radical hysterectomy on the quality of sexual life for patients with early-stage cervical cancer: trial protocol for a multi-center superiority randomized controlled trial.
2024cited by 1position: contributordoi
Intraoperative frozen section pathology of vaginal margin in radical hysterectomy on the prognosis and quality of life for patients with IB2-IIA2 cervical cancer: study protocol for a multicenter randomized controlled trial.
2024cited by 0position: contributordoi
Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome.
2023cited by 77position: contributordoi
Single‐Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus‐Associated (HPVA) and Non‐HPVA Adenocarcinoma
Advanced Science 2023cited by 62position: lastdoi
Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3<sup>+</sup> dendritic cells with CD4<sup>+</sup> regulatory T cells and CD8<sup>+</sup> exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implications.
2023cited by 55position: contributordoi
Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma.
2023cited by 48position: contributordoi
The biological roles of CD24 in ovarian cancer: old story, but new tales
Frontiers in Immunology 2023cited by 28position: lastdoi
A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial).
2023cited by 9position: contributordoi
Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer.
2023cited by 6position: contributordoi
Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a randomized controlled trial (C-PACC trial).
2023cited by 3position: contributordoi
Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health
Frontiers in Endocrinology 2022cited by 95position: lastdoi
Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer.
2022cited by 72position: contributordoi
The extracellular vesicular pseudogene LGMNP1 induces M2-like macrophage polarization by upregulating LGMN and serves as a novel promising predictive biomarker for ovarian endometriosis recurrence.
2022cited by 32position: contributordoi
Vaginal Microbial Environment Skews Macrophage Polarization and Contributes to Cervical Cancer Development.
2022cited by 17position: contributordoi
Scrutinizing high-risk patients from ASC-US cytology via a deep learning model.
2022cited by 10position: contributordoi
HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis.
2022cited by 7position: contributordoi
Single-port laparoscopy versus conventional laparoscopy of benign adnexal masses during pregnancy: a retrospective case-control study.
2022cited by 5position: contributordoi
An Investigation of Depressive Symptoms in Patients with Congenital Cervical and Vaginal Aplasia: A Cross-Sectional Study.
2022cited by 4position: contributordoi
Factors Associated with Patient Survival in Clear Cell Adenocarcinoma of the Cervix: A Single-Center Experience in China.
2022cited by 3position: contributordoi
Diagnostic Dilemma of Retroperitoneal Schwannomas Encountered in a Specialized Gynecology Hospital.
2022cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 39 papers (2019–2026)Junjun Qiu · Fudan University6 papers (2013–2023)Jing Xin Ding · Obstetrics and Gynecology Hospital of Fudan University6 papers (2022–2026)Weiwei Feng · Fudan University4 papers (2013–2019)Jingxin Ding · Fudan University4 papers (2013–2023)Yuanyuan Gu · Shandong University3 papers (2022–2025)Yingying Lin · Beijing Technology and Business University3 papers (2014–2022)Yinhua Yu · Fudan University3 papers (2013–2019)Nan Jia · China-Japan Friendship Hospital3 papers (2013–2019)J J Qiu · Obstetrics and Gynecology Hospital of Fudan University3 papers (2022–2023)Guannan Zhou · Karolinska University Hospital3 papers (2022–2025)Wenjun Cheng · Nanjing Tech University2 papers (2020–2020)Xiaohui Yan · Shanxi Medical University2 papers (2013–2013)Robert C. Bast · The University of Texas at Austin2 papers (2013–2019)Ping Wang · Shihezi University2 papers (2020–2021)Ying Zhang · Shenyang Medical College2 papers (2014–2016)Hongyan Jin · Fudan University2 papers (2013–2014)Xiaoyan Tang · Shanghai Medical College of Fudan University2 papers (2019–2019) · 2 papers (2022–2025)Guannan Zhou · Fudan University2 papers (2022–2022)